Knockdown of insulin-like growth factor 1 receptor enhances chemosensitivity to cisplatin in human lung adenocarcinoma A549 cells

Acta Biochimica et Biophysica Sinica

Volumn 40, Issue 6, 2008, Pages 497-504

  Dong, Aiqiang ^a   Kong, Minjian ^a   Ma, Zhiyuan ^b   Qian, Jianfang ^a   Cheng, Haifeng ^a   Xu, Xiaohong ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

Chemosensitivity; Cisplatin; Insulin like growth factor 1 receptor; Lung cancer; RNA interference

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; SOMATOMEDIN C RECEPTOR;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; CELL SURVIVAL; DOSE RESPONSE; DRUG EFFECT; GENE SILENCING; GENE TARGETING; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; METHODOLOGY; PATHOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE SILENCING; GENE TARGETING; HUMANS; LUNG NEOPLASMS; RECEPTOR, IGF TYPE 1;

MUS MUSCULUS;

EID: 45349102931     PISSN: 16729145     EISSN: 17457270     Source Type: Journal    
DOI: 10.1111/j.1745-7270.2008.00429.x     Document Type: Article

References (31)

1. Mezzetti M, Panigalli T, Giuliani L, Raveglia F, Giudice FL, Meda S. Personal experience in lung cancer sleeve lobectomy and sleeve pneumonectomy. Ann Thorac Surg 2002, 73 : 1736 1739.
2. Greenlee RT, Murray T, Bolden S, Wingo PA. Cancer statistics. CA Cancer J Clin 2000, 50 : 7 33.
3. Bunn PA Jr., Kelly K. New combinations in the treatment of lung cancer: a time for optimism. Chest 2000, 117 : 138 143.
4. Yarden Y, Ullrich A. Growth factor receptor tyrosine kinases. Annu Rev Biochem 1988, 57 : 443 478.
5. Williams LT. Signal transduction by the platelet-derived growth factor receptor. Science 1989, 243 : 1564 1570.
6. Cantley LC, Auger KR, Carpenter C, Duckworth B, Graziani A, Kapeller R. Oncogenes and signal transduction. Cell 1991, 64 : 281 302.
7. Schlessinger J. Signal transduction by allosteric receptor oligomerization. Trends Biochem Sci 1988, 13 : 443 447.
8. Yarden Y, Schlessinger J. Epidermal growth factor induces rapid, reversible aggregation of the purified epidermal growth factor receptor. Biochemistry 1987, 26 : 1443 1451.
9. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocr Rev 1995, 16 : 143 163.
10. Kaleko M, Rutter WJ, Miller AD. Overexpression of the human insulinlike growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 1990, 10 : 464 473.
11. Remacle-Bonnet MM, Garrouste FL, Heller S, Andre F, Marvaldi JL, Pommier GJ. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways. Cancer Res 2000, 60 : 2007 2017.
12. Singh P. Insulin-like growth factor system in growth, development and carcinogenesis. J Clin Lig Assay 2000, 23 : 214 232.
13. Scotlandi K, Maini C, Manara MC, Benini S, Serra M, Cerisano V, Strammiello R et al. Effectiveness of insulin-like growth factor I receptor antisense strategy against Ewing's sarcoma cells. Cancer Gene Ther 2002, 9 : 296 307.
14. Turner BC, Haffty BG, Narayanan L, Yuan J, Havre PA, Gumbs AA, Kaplan L et al. Insulin-like growth factor-I receptor overexpression mediates cellular radioresistance and local breast cancer recurrence after lumpectomy and radiation. Cancer Res 1997, 57 : 3079 3083.
15. Wu Y, Tewari M, Cui S, Rubin R. Activation of the insulin-like growth factor-I receptor inhibits tumor necrosis factor-induced cell death. J Cell Physiol 1996, 168 : 499 509.
16. Dong AQ, Kong MJ, Ma ZY, Qian JF, Xu XH. Down-regulation of IGF-IR using small, interfering, hairpin RNA (siRNA) inhibits growth of human lung cancer cell line A549 in vitro and in nude mice. Cell Biol Int 2007, 31 : 500 507.
17. Qian J, Dong A, Kong M, Ma Z, Fan J, Jiang G. Suppression of type 1 Insulin-like growth factor receptor expression by small interfering RNA inhibits A549 human lung cancer cell invasion in vitro and metastasis in xenograft nude mice. Acta Biochim Biophys Sin 2007, 39 : 137 147.
18. Dong AQ, Kong MJ, Ma ZY, Qian JF, Fan JQ, Xu XH. shRNA-mediated insulin-like growth factor I receptor gene silencing inhibits cell proliferation, induces cell apoptosis, and suppresses tumor growth in non-small cell lung cancer: in vitro and in vivo experiments. Zhonghua Yi Xue Za Zhi 2007, 87 : 1506 1509.
19. Kulik G, Klippel A, Weber MJ. Antiapoptotic signaling by the insulin-like growth factor I receptor, phosphatidylinositol 3-kinase, and Akt. Mol Cell Biol 1997, 17 : 1595 1606.
20. Rochester MA, Riedemann J, Hellawell GO, Brewster SF, Macaulay VM. Silencing of the IGF1R gene enhances sensitivity to DNA-damaging agents in both PTEN wild-type and mutant human prostate cancer. Cancer Gene Ther 2005, 12 : 90 100.
21. Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 1999, 91 : 620 625.
22. Scotlandi K, Benini S, Nanni P, Lollini PL, Nicoletti G, Landuzzi L, Serra M et al. Blockage of insulin-like growth factor-I receptor inhibits the growth of Ewing's sarcoma in athymic mice. Cancer Res 1998, 58 : 4127 4131.
23. Chernicky CL, Yi L, Tan H, Gan SU, Ilan J. Treatment of human breast cancer cells with antisense RNA to the type I insulin-like growth factor receptor inhibits cell growth, suppresses tumorigenesis, alters the metastatic potential, and prolongs survival in vivo. Cancer Gene Ther 2000, 7 : 384 395.
24. Lee CT, Wu S, Gabrilovich D, Chen H, Nadaf-Rahrov S, Ciernik IF, Carbone DP. Antitumor effects of an adenovirus expressing antisense insulin-like growth factor I receptor on human lung cancer cell lines. Cancer Res 1996, 56 : 3038 3041.
25. Yuen JS, Macaulay VM. Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer. Expert Opin Ther Targets 2008, 12 : 589 603.
26. Lee CT, Park KH, Adachi Y, Seol JY, Yoo CG, Kim YW, Han SK et al. Recombinant adenoviruses expressing dominant negative insulin-like growth factor-I receptor demonstrate anti-tumor effects on lung cancer. Cancer Gene Ther 2003, 10 : 57 63.
27. Zhang H, Pelzer AM, Kiang DT, Yee D. Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin. Cancer Res 2007, 67 : 391 397.
28. Beech DJ, Parekh N, Pang Y. Insulin-like growth factor-I receptor antagonism results in increased cytotoxicity of breast cancer cells to doxorubicin and taxol. Oncol Rep 2001, 8 : 325 329.
29. Niu J, Xu Z, Li XN, Han Z. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53. Cell Biol Int 2007, 31 : 156 164.
30. Maloney EK, McLaughlin JL, Dagdigian NE Garrett LM, Connors KM, Zhou XM, Blattler WA et al. An anti-insulin-like growth factor I receptor antibody that is a potent inhibitor of cancer cell proliferation. Cancer Res 2003, 63 : 5073 5083.
31. Hellawell GO, Ferguson DJ, Brewster SF, Macaulay VM. Chemosensitization of human prostate cancer using antisense agents targeting the type 1 insulin-like growth factor receptor. Br J Urol 2003, 91 : 271 277.